AAM
SRRA

Alpine Associates Management’s Sierra Oncology, Inc. Common Stock SRRA Stock Holding History

Alpine Associates Management’s Portfolio SRRA Stock Details SRRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-472,200
Closed -$26M – 69
2022
Q2 		$26M Buy
+472,200
New +$24.8M 0.98% 37

Other funds holding SRRA

HI
Harbour Investments Madison, Wisconsin $6.48B AUM 18.23% 1-Year Est. Return

Alpine Associates Management's SRRA Position: Q3 2022 in Review

Alpine Associates Management sold out of Sierra Oncology, Inc. Common Stock (SRRA) in Q3 2022, closing a stake of 472,200 shares — an estimated $26M sold.

Alpine Associates Management first reported a position in SRRA in Q2 2022 and held it in 1 quarter. The position peaked at $26M in Q2 2022. 1 fund tracked by Wall St. Rank holds SRRA as of Q3 2022.

  • Alpine Associates Management reported no remaining Sierra Oncology, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • Alpine Associates Management sold 472,200 Sierra Oncology, Inc. Common Stock shares in Q3 2022, an estimated $26M.
  • Alpine Associates Management first reported a position in Sierra Oncology, Inc. Common Stock in Q2 2022 and held it in 1 quarter.
  • Alpine Associates Management's Sierra Oncology, Inc. Common Stock position peaked at $26M in Q2 2022.
  • 1 fund tracked by Wall St. Rank held Sierra Oncology, Inc. Common Stock as of Q3 2022.

Based on Alpine Associates Management's 13F filing for Q3 2022, filed 10 Nov 2022.